Project Grant R01AG103829
Award Date 9/3/26
Completion Date 5/31/31
Dollars Obligated $674K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
- The National Institute on Aging awarded The Johns Hopkins University $769,960 under the Aging Research program (CFDA 93.866) on September 1, 2026, for research examining how changes in home health care agency ownership and private capital investment affect access to care, quality of care, and patient outcomes for people living with dementia. The project, which runs through May 31, 2031, investigates the impact of multi-state chain acquisitions and private capital investments on home health...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded $691,306 to Trustees of Indiana University (Indiana University Indianapolis) on August 15, 2026, under the Aging Research program (CFDA 93.866). The award funds research integrating real-world evidence from electronic medical records, cell line assays, and single-cell omics via deep reinforcement learning to identify repurposable drugs for Alzheimer's disease treatment. The project applies deep transfer...
- The National Institute on Aging awarded Trustees of Indiana University (doing business as Indiana University Indianapolis) $791,039 on September 1, 2026, under the Aging Research program (CFDA 93.866) to develop computational methods enabling patient-centered prognostic profiling for Alzheimer's disease and related dementias that accounts for individual cognitive resilience in response to neuropathological changes. The work will model each patient's distinct connectome architecture and cognitive...
- The National Institute on Aging awarded Trustees of Indiana University $433,593 on July 1, 2026, under the Aging Research program (CFDA 93.866) to integrate Centers for Medicare and Medicaid Services Medicare fee-for-service and Medicare Advantage inpatient data to improve hospital quality, outcomes, and disparities measurement. The project addresses a measurement gap created by Medicare Advantage enrollment growth to 55 percent of beneficiaries with Medicare Parts A and B coverage. Despite this...
- The National Institute on Aging awarded Trustees of Indiana University $561,748 on September 2, 2026, under the Aging Research program (CFDA 93.866) to conduct the Study of Dementia Care Staff: Adaptation of Instruments for Multinational Research (SUSTAIN). The SUSTAIN project will adapt a U.S.-based survey and develop internationally validated measures for dementia care workers across four countries spanning three continents: the United States, Brazil, Switzerland, and Ghana. Aim 1 involves...
- The National Institute on Aging awarded Wake Forest University Health Sciences $633,510 on September 1, 2026, under the Aging Research program (CFDA 93.866) to examine the impact of home-based medical care and telemedicine use on dementia care outcomes among Medicare enrollees with Alzheimer's disease and related dementias. The project will study home-based medical care delivery—house calls by physicians and advanced care providers—and telemedicine use among persons living with Alzheimer's...
- The National Institute on Aging awarded the Trustees of Indiana University $1.232 million on February 1, 2026, under the Aging Research program (CFDA 93.866) to develop AI-driven virtual screening pipelines and computational tools for identifying blood-brain-barrier-penetrant drug candidates against Alzheimer's disease and related dementias. The funded research encompasses three interconnected aims: developing AI-driven virtual screening pipelines incorporating small-molecule foundation...
- The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute...
- The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $734,346 on August 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a mixed-method, sequential explanatory study examining how private equity acquisition of hospice agencies affects end-of-life care and outcomes for people living with Alzheimer's disease and related disorders. The research quantifies associations between private equity acquisition and hospice use, quality, and...
- The University of California, Los Angeles received a $2.7 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded September 1, 2025, with completion scheduled for August 31, 2029. This research project will generate rigorous evidence comparing health outcomes for older patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) who are discharged from hospitals to home-based care versus facility-based...